Comments to FDA: Proposal to Revise CP Regulation Share page: CHPA submits these comments on the proposal published by the Food and Drug Administration in 64 Fed. Reg. 66822 (November 30, 1999) to revise its citizen petition regulations, 21 C.F.R. § 10.25 and 21 C.F.R. § 10.30. Download Document Issues: OTC Medicines Related Posts Regulation of OTC Medicines Press Releases and Statements CHPA Congratulates Dr. Doug Bierer as First Recipient of the William Cooley Regulatory & Scientific Affairs Career Achievement Award Sep 18, 2024 Press Releases and Statements Health In Hand Foundation Announces 2024 U.S. Self-Care Marketing Awards Finalists Sep 9, 2024